XT
PYXS icon

XTX Topco’s Pyxis Oncology PYXS Stock Holding History

XTX Topco’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
110,939
-89,157
-45% -$170K ﹤0.01% 2818
2026
Q1 		$292K Sell
200,096
-88,937
-31% -$134K 0.01% 2505
2025
Q4 		$332K Buy
289,033
+271,334
+1,533% +$957K 0.01% 1974
2025
Q3 		$39.3K Sell
17,699
-18,681
-51% -$26.9K ﹤0.01% 2211
2025
Q2 		$40K Buy
+36,380
New +$41K ﹤0.01% 2062
2025
Q1 		– Sell
-22,492
Closed -$35.1K – 2965
2024
Q4 		$35.1K Sell
22,492
-62,279
-73% -$180K ﹤0.01% 1956
2024
Q3 		$311K Buy
84,771
+48,481
+134% +$170K 0.02% 1154
2024
Q2 		$120K Sell
36,290
-29,572
-45% -$124K 0.01% 1376
2024
Q1 		$281K Buy
65,862
+45,303
+220% +$191K 0.04% 914
2023
Q4 		$37K Buy
+20,559
New +$35.2K 0.01% 1286
2023
Q3 		– Sell
-15,236
Closed -$39K – 1927
2023
Q2 		$39K Buy
+15,236
New +$48.3K 0.01% 1268

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's PYXS Position: Q2 2026 in Review

XTX Topco reduced its Pyxis Oncology (PYXS) stake by 45% in Q2 2026, selling an estimated $170K and leaving 110,939 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.

XTX Topco first reported a position in PYXS in Q2 2023 and has held it in 11 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • XTX Topco held 110,939 shares of Pyxis Oncology worth $334K as of Q2 2026.
  • XTX Topco sold 89,157 Pyxis Oncology shares in Q2 2026, an estimated $170K.
  • Pyxis Oncology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2818 holding.
  • XTX Topco first reported a position in Pyxis Oncology in Q2 2023 and has held it in 11 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.